Free Trial
CVE:RX

BioSyent (RX) Stock Price, News & Analysis

BioSyent logo
C$11.70 -0.10 (-0.85%)
As of 01:44 PM Eastern

About BioSyent Stock (CVE:RX)

Key Stats

Today's Range
C$11.70
C$11.70
50-Day Range
C$10.25
C$12.00
52-Week Range
C$9.20
C$12.13
Volume
206 shs
Average Volume
4,414 shs
Market Capitalization
C$133.82 million
P/E Ratio
18.99
Dividend Yield
1.54%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

RX Stock News Headlines

Biosyent Inc. Stock Price History
BioSyent (CVE:RX) Has Announced A Dividend Of CA$0.05
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
BioSyent Inc. (RX.V)
See More Headlines

RX Stock Analysis - Frequently Asked Questions

BioSyent's stock was trading at C$11.00 at the beginning of the year. Since then, RX shares have increased by 7.3% and is now trading at C$11.80.
View the best growth stocks for 2025 here
.

BioSyent Inc. (CVE:RX) released its quarterly earnings results on Thursday, May, 25th. The company reported $0.06 EPS for the quarter, missing analysts' consensus estimates of $0.08 by $0.02. The company earned $3.82 million during the quarter, compared to analyst estimates of $4.80 million. BioSyent had a net margin of 20.60% and a trailing twelve-month return on equity of 20.01%.

Shares of RX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioSyent investors own include Aurora Cannabis (ACB), Astec Industries (ASTE), Bank of Nova Scotia (BNS), Carnival (CCL), Cisco Systems (CSCO), Devon Energy (DVN) and Ford Motor (F).

Company Calendar

Last Earnings
5/25/2017
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:RX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
18.99
Forward P/E Ratio
16.85
P/E Growth
N/A
Net Income
C$7.02 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$34.06 million
Cash Flow
C$3.81 per share
Price / Cash Flow
3.07
Book Value
C$3.22 per share
Price / Book
3.63

Miscellaneous

Free Float
N/A
Market Cap
C$133.82 million
Optionable
Not Optionable
Beta
0.93
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (CVE:RX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners